216 related articles for article (PubMed ID: 8774479)
21. Mucinous bronchioloalveolar carcinoma with K-ras mutation arising in type 1 congenital cystic adenomatoid malformation: a case report with review of the literature.
Ishida M; Igarashi T; Teramoto K; Hanaoka J; Iwai M; Yoshida K; Kagotani A; Tezuka N; Okabe H
Int J Clin Exp Pathol; 2013; 6(11):2597-602. PubMed ID: 24228126
[TBL] [Abstract][Full Text] [Related]
22. Papillary adenocarcinoma of the lung is a more advanced adenocarcinoma than bronchioloalveolar carcinoma that is composed of two distinct histological subtypes.
Jian Z; Tomizawa Y; Yanagitani N; Iijima H; Sano T; Nakajima T
Pathol Int; 2005 Oct; 55(10):619-25. PubMed ID: 16185291
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological features of lung adenocarcinoma with KRAS mutations.
Kakegawa S; Shimizu K; Sugano M; Miyamae Y; Kaira K; Araki T; Nakano T; Kamiyoshihara M; Kawashima O; Takeyoshi I
Cancer; 2011 Sep; 117(18):4257-66. PubMed ID: 21387273
[TBL] [Abstract][Full Text] [Related]
24. [Frequency and clinicopathological associations of K-ras mutations in Venezuelan patients with colo-rectal cancer].
Estrada P; Rojas-Atencio A; Zabala W; Borjas L; Soca L; Urdaneta K; Alvarez-Nava F; Cañizales J; Rojas J; Soto M
Invest Clin; 2009 Mar; 50(1):55-63. PubMed ID: 19418727
[TBL] [Abstract][Full Text] [Related]
25. Expression of E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin in bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma: an immunohistochemical study.
Hidaka N; Nagao T; Asoh A; Kondo Y; Nagao K
Mod Pathol; 1998 Nov; 11(11):1039-45. PubMed ID: 9831199
[TBL] [Abstract][Full Text] [Related]
26. c-k-ras and p53 mutations occur very early in adenocarcinoma of the lung.
Li ZH; Zheng J; Weiss LM; Shibata D
Am J Pathol; 1994 Feb; 144(2):303-9. PubMed ID: 8311114
[TBL] [Abstract][Full Text] [Related]
27. Expression of MUC1, MUC2, MUC5AC, and MUC6 in atypical adenomatous hyperplasia, bronchioloalveolar carcinoma, adenocarcinoma with mixed subtypes, and mucinous bronchioloalveolar carcinoma of the lung.
Awaya H; Takeshima Y; Yamasaki M; Inai K
Am J Clin Pathol; 2004 May; 121(5):644-53. PubMed ID: 15151204
[TBL] [Abstract][Full Text] [Related]
28. Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy.
Mok SC; Bell DA; Knapp RC; Fishbaugh PM; Welch WR; Muto MG; Berkowitz RS; Tsao SW
Cancer Res; 1993 Apr; 53(7):1489-92. PubMed ID: 8384077
[TBL] [Abstract][Full Text] [Related]
29. Expression of thyroid transcription factor-1, cytokeratin 7, and cytokeratin 20 in bronchioloalveolar carcinomas: an immunohistochemical evaluation of 67 cases.
Lau SK; Desrochers MJ; Luthringer DJ
Mod Pathol; 2002 May; 15(5):538-42. PubMed ID: 12011259
[TBL] [Abstract][Full Text] [Related]
30. Mucinous and nonmucinous bronchioloalveolar adenocarcinomas have distinct staining patterns with thyroid transcription factor and cytokeratin 20 antibodies.
Goldstein NS; Thomas M
Am J Clin Pathol; 2001 Sep; 116(3):319-25. PubMed ID: 11554157
[TBL] [Abstract][Full Text] [Related]
31. CD44v6 expression in primary bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma.
Ohori NP; Coppola D; Landreneau RJ
Mod Pathol; 1996 May; 9(5):507-12. PubMed ID: 8733765
[TBL] [Abstract][Full Text] [Related]
32. Comparison of extracellular matrix antigens in subtypes of bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma. An immunohistochemical study.
Ohori NP; Yousem SA; Griffin J; Stanis K; Stetler-Stevenson WG; Colby TV; Sonmez-Alpan E
Am J Surg Pathol; 1992 Jul; 16(7):675-86. PubMed ID: 1326898
[TBL] [Abstract][Full Text] [Related]
33. Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.
Yamada T; Nakamori S; Ohzato H; Oshima S; Aoki T; Higaki N; Sugimoto K; Akagi K; Fujiwara Y; Nishisho I; Sakon M; Gotoh M; Monden M
Clin Cancer Res; 1998 Jun; 4(6):1527-32. PubMed ID: 9626473
[TBL] [Abstract][Full Text] [Related]
34. LKB1 mutations frequently detected in mucinous bronchioloalveolar carcinoma.
Osoegawa A; Kometani T; Nosaki K; Ondo K; Hamatake M; Hirai F; Seto T; Sugio K; Ichinose Y
Jpn J Clin Oncol; 2011 Sep; 41(9):1132-7. PubMed ID: 21816872
[TBL] [Abstract][Full Text] [Related]
35. KRAS and BRAF mutations in ovarian tumors: a comprehensive study of invasive carcinomas, borderline tumors and extraovarian implants.
Mayr D; Hirschmann A; Löhrs U; Diebold J
Gynecol Oncol; 2006 Dec; 103(3):883-7. PubMed ID: 16806438
[TBL] [Abstract][Full Text] [Related]
36. Bronchioloalveolar carcinoma of the lung 3 centimeters or less in diameter: a prognostic assessment.
Sakurai H; Dobashi Y; Mizutani E; Matsubara H; Suzuki S; Takano K; Shindo S; Matsumoto M
Ann Thorac Surg; 2004 Nov; 78(5):1728-33. PubMed ID: 15511463
[TBL] [Abstract][Full Text] [Related]
37. k-ras mutation and occupational asbestos exposure in lung adenocarcinoma: asbestos-related cancer without asbestosis.
Nelson HH; Christiani DC; Wiencke JK; Mark EJ; Wain JC; Kelsey KT
Cancer Res; 1999 Sep; 59(18):4570-3. PubMed ID: 10493509
[TBL] [Abstract][Full Text] [Related]
38. Clonality and K-ras mutation analyses of epithelia in intraductal papillary mucinous tumor and mucinous cystic tumor of the pancreas.
Yoshizawa K; Nagai H; Sakurai S; Hironaka M; Morinaga S; Saitoh K; Fukayama M
Virchows Arch; 2002 Nov; 441(5):437-43. PubMed ID: 12447672
[TBL] [Abstract][Full Text] [Related]
39. Non-mucinous and mucinous subtypes of adenocarcinoma with bronchioloalveolar carcinoma features differ by biomarker expression and in the response to gefitinib.
Wislez M; Antoine M; Baudrin L; Poulot V; Neuville A; Pradere M; Longchampt E; Isaac-Sibille S; Lebitasy MP; Cadranel J
Lung Cancer; 2010 May; 68(2):185-91. PubMed ID: 19581016
[TBL] [Abstract][Full Text] [Related]
40. Can K-ras-mutated atypical adenomatous hyperplasia be another precursor lesion for mucinous bronchioloalveolar carcinoma?
Garfield D
Am J Clin Pathol; 2008 Aug; 130(2):315-6; author reply 316. PubMed ID: 18697292
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
